The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung
- 1 February 2003
- journal article
- Published by Elsevier in Human Pathology
- Vol. 34 (2) , 136-142
- https://doi.org/10.1053/hupa.2003.8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Alterations of expression of Rb, p16INK4A and cyclin D1 in non-small cell lung carcinoma and their clinical significanceThe Journal of Pathology, 1999
- Cancer Cell CyclesScience, 1996
- CYCLIN D1 OVEREXPRESSION IN NON-SMALL CELL LUNG CARCINOMA: CORRELATION WITH Ki67 LABELLING INDEX AND POOR CYTOPLASMIC DIFFERENTIATIONThe Journal of Pathology, 1996
- Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: An immunohistochemical studyInternational Journal of Cancer, 1996
- Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancerBritish Journal of Cancer, 1996
- Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16Nature, 1995
- Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer.Proceedings of the National Academy of Sciences, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.Molecular and Cellular Biology, 1994
- Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.Genes & Development, 1993